Request Study Information

After you submit your request, a staff member will contact you.There’s no obligation and our team is here to help you decide on a study that’s best for you.

A Phase 2a, Randomized, Double-blind, Placebo-controlled, Multiple-dose, Crossover Study of the Effect of ZT-01 on Frequency of Nocturnal Hypoglycemia in Type 1 Diabetes Mellitus

Rovia Jacksonville – Southside (ECIR Site), Rovia Macon (ECIR Site)

The study drug ZT-01 is designed to inhibit somatostatin, a hormone that inhibits the glucagon response to hypoglycemia. Thus, ZT-01 may be able to restore glucagon production to prevent hypoglycemia, which could improve both health and quality of life in people with T1DM.

The purpose of this study is:

To assess the effect of ZT-01 days on incidence of night time (nocturnal) hypoglycemia in participants with T1DM;
To assess the safety and tolerability of study drug ZT-01;
To look for study drug’s safety indicators (called safety biomarkers);
To understand how the study drug is changed by and removed from the body (called pharmacokinetic or PK testing);
To understand how the study drug is affecting the body (called PD testing).

Enter Your Information

(All fields are required)

Study Request Form (specific)

Name(Required)

First Name Last Name

Phone Number(Required)

Email Address(Required)

Zip / Postal Code(Required)

Date of Birth(Required)

Gender(Required)

Preferred Location(Required)

Study Of Interest(Required)

Preferred Language(Required)

Are you Hispanic or Latino(Required)

Race(Required)

Select one or more options that best describe you. This information can help ensure that all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and consent to receiving communications (e.g., call, SMS, text, and/or email) from ECIR and/or the research site(s) involved with the clinical trials that appear on this website. Messaging frequency varies. Message and data rates may apply. You may reply with STOP to a text message. For any help regarding messaging, please email us at [email protected]. For full details, refer to ECIR’s privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

CAPTCHA

Headquarters
3550 University Blvd South, Suite #101
Jacksonville, FL 32216

Tel: (904) 854-1354
Fax: (904) 854-1355